Market Data graphic

Life Sciences

You are here

The Life Sciences sector includes companies involved in biopharmaceuticals, medical manufacturing and distribution, and bio products.

Life sciences companies listed on CSE

MPX International Corporation is a multinational diversified cannabis company focused on developing and operating assets across the international cannabis industry with an emphasis on cultivating, manufacturing and marketing products which include cannabinoids as their primary active ingredient. With current operations spanning four continents in Canada, Switzerland, South Africa, Malta and Thailand as well as evolving partnership and distribution opportunities in other jurisdictions, MPXI continues to position itself as an emergent global participant in the cannabis industry.

MTL Cannabis is the parent company of Montréal Medical Cannabis Inc., a licensed producer headquartered in Montréal, Québec and operating from a 57,000 sq ft licensed indoor grow facility in Pointe Claire, Québec; Abba Medix Corp., a licensed producer in Pickering, Ontario that operates a leading medical cannabis marketplace; IsoCanMed Inc., a licensed producer in Louiseville, Québec growing best-in-class indoor cannabis, in its 64,000 sq. ft. production facility; and Canada House Clinics Inc., with clinics across Canada that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from simple and complex medical conditions.

 

 

Mynd is a life sciences based neuro-pharmaceutical drug development company advancing medicines that leverage psychedelic compounds. Our mission is to further our existing research and patents linking depression and inflammation at the genetic and cellular level to develop pharmaceutical treatments.

MyndTec is a Canadian medical technology company dedicated to the development and commercialization of innovative products that improve function, maximize independence and enhance the quality of life for individuals who have suffered injury to the central nervous system as a result of stroke, spinal cord injury and certain traumatic brain injuries.  

NanoSphere Health Sciences is a biotechnology company that has developed and is commercializing its patented NanoSphere Delivery System™, a ground breaking platform using nanotechnology for the delivery of biological agents such as cannabinoids, supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries, and beyond.  The NanoSphere Delivery System™ provides improved bioavailability, efficacy and onset of effect over traditional delivery systems, and represents one of the most important developments for advancing the non-invasive and user-friendly delivery of biological agents in over 25 years.    Under the brand name “Evolve”, NanoSphere has already launched its acclaimed NanoSerum™  product for the recreational and medical cannabis markets in Colorado, and will build on that success by opening new markets for Evolve and developing and commercializing new applications for NanoSerum™.

Nass Valley Gateway has completed the acquisition of two wholly owned subsidiaries Advanced Bioceuticals Limited (“ABL”), incorporated under the Laws of New Jersey and Pro-Thotics Technology Inc. (“PTI”), a New York corporation with a more than 25 year established business. Through its subsidiary PTI the Company will continue to focus on expanding the sale of Durable Medical Equipment (“DME-Products”)and increasing its database of more than 200,000 patients with service of providing relief from pain and medical issues via its DME-Products. Through its subsidiary ABL the Company is determined to expand upon this pain relief concept and to commence the sale of Cannabidiol (CBD) with zero THC content for internal use including CBD infused skin, bath, and body care products.

nDatalyze Corp. generates technology-based, health-related solutions. It’s 100%-owned US subsidiary, Mindbalanced Inc., offers mental health assessments and treatment options in the US. Investors are encouraged to contact the Corporation by email at jimd@ndatalyze.com or by telephone at (403) 689-3901.

NetraMark Holdings is an AI healthtech company focused on addressing both acute and non-acute brain-centric conditions. We have developed an ecosystem of innovative products that directly support brain-related conditions. Our world-renowned team and partners are disrupting traditional mental wellness treatments and are positioned at the forefront of critical research and innovations. NetraMark, a wholly owned subsidiary of NetraMark Holdings Inc., is providing proprietary next-generation AI solutions for pharmaceutical and biotechnology companies across the spectrum of disease. The company is based in Toronto, Ontario. For more information, visit https://www.netramark.com/ .

 

Nevis innovates and develops cannabis products that have been consumed by millions of consumers across multiple markets in the United States.  Led by our flagship brand Major(TM) Nevis partners with leading cannabis product manufacturers and distributors to enhance their product offerings.

The Issuer will provide consulting services, real property, intellectual property, equipment for lease and enhanced ancillary services to a licensed cannabis processor.

Contact The Team

How can we help you?

Contact the CSE team to find out more.